In vivo Temperature Assessment during Holmium Laser Enucleation of the Prostate.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2023
Historique:
received: 06 10 2022
accepted: 19 12 2022
medline: 29 5 2023
pubmed: 2 3 2023
entrez: 1 3 2023
Statut: ppublish

Résumé

Holmium laser enucleation of the prostate (HoLEP) has become popular worldwide for the surgical treatment of benign prostate hyperplasia. Holmium laser is considered an ideal transurethral thermomechanical device for enucleating the prostate. Although there is evidence on Ho:YAG laser-related heat generation, the studies mainly investigated ex vivo temperature generation during holmium laser lithotripsy. In this in vivo study, we aimed to assess for the first time the real-time heat generated during HoLEP. Fifteen HoLEP procedures were included. The study was conducted over a time period of 16 months. To investigate the temperature generation, a preoperatively inserted rectal temperature probe and a temperature sensor within a suprapubic bladder catheter were used to record the temperature change during enucleation and coagulation. The mean values of the temperature change during the laser enucleation and coagulation were -0.35 ± 0.203 K (IQR: 0.23) and +0.14 ± 0.259 K (IQR: 0.3), respectively, in rectal measurements. Temperature differences during laser use and coagulation were <+1 K and <+5 K, respectively, in bladder measurements. We measured no temperature >37.1°C during the procedures and no temperature values considered harmful to the human body. Sufficient irrigation flow rates and irrigation monitoring during HoLEP are obligatory. To prevent a high and uncontrolled temperature rise, the surgeon or operating room staff should pay attention to the irrigation's continuity.

Identifiants

pubmed: 36858035
pii: 000528849
doi: 10.1159/000528849
doi:

Substances chimiques

Holmium W1XX32SQN1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-369

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Mehmet Yilmaz (M)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany, mehmet.yilmaz@uniklinik-freiburg.de.

Cäcilia Elisabeth Maria Heuring (CEM)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Dominik Schoeb (D)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Rodrigo Suarez-Ibarrola (R)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Christian Gratzke (C)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Simon Hein (S)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Arkadiusz Miernik (A)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH